Prosecution Insights
Last updated: May 29, 2026

BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

151 pending office actions • 88 art units • 141 examiners • 0 of 151 (0%) have an AI response strategy ready • 145 patents granted in the last 365 days

Portfolio Summary

151
Total Pending OAs
100
Non-Final OAs
44
Final Rejections
7
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 151 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

87
Overdue
12
Due this week
34
Due this month
9
Due in next 60 days
9
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 151 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (87)Due ≤ 7 days (12)Due ≤ 30 days (34)Due ≤ 60 days (9)Due later (9)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (3%)
115
Medium (76%)
12
Easy (8%)
19
Unknown (13%)

Rejection Statute Mix

BucketCases
§101 only5 (3%)
§103 only107 (71%)
§102 only7 (5%)
§112 only12 (8%)
Double-patenting + other1 (1%)
No statute on record19 (13%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

106
Life Sciences
70% of docket
8
Information Tech
5% of docket
1
Communications
1% of docket
10
Semiconductors
7% of docket
26
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,510 h
Manual time on pending OAs
302 h
Time saved (low, 20%)
528 h
Time saved (mid, 35%)
13.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JONES, DAMERON LEVEST 3 67.7% +31.5%
MEYERS, ELIZABETH ANNE 2 23.1% +100.0%
HAMMOND, ELLEN CHRISTINA 2 78.0% +11.8%
BELL, SARA ELIZABETH 2 73.5% +39.9%
PETERSON, ERIK T 2 76.9% +11.8%
EBBINGHAUS, BRIANA NOEL 2 57.4% +67.0%
LI, BAO Q 2 75.9% +26.2%
LEONARD, ARTHUR S 2 50.5% +50.7%
PATTERSON, SARAH COOPER 2 58.6% +56.4%
BRUCE, FAROUK A 1 46.1% +37.0%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18308921 PROACTIVE SEISMIC REHABILITATION OF WATER PIPE NETWORKS FOR EQUITABLE RECOVERY ABOUZAHRA, REHAM K 146d overdue
18023483 METHODS FOR FINE NEEDLE SAMPLE ANALYSIS VIA MASS SPECTROMETRY FRITCHMAN, REBECCA M 71d overdue
17222924 SYSTEM AND METHOD FOR HUMAN ACTION RECOGNITION AND INTENSITY INDEXING FROM VIDEO STREAM USING FUZZY ATTENTION MACHINE LEARNING SMITH, KEVIN LEE 66d overdue
17774298 HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOF PATTERSON, SARAH COOPER 23d overdue
18688180 COMPOSITIONS AND METHODS FOR TREATING BONE INJURIES MEYERS, ELIZABETH ANNE 19d overdue
17980435 BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS CHERNYSHEV, OLGA N 28d
17777102 INCLUSION COMPLEXES OF PHARMACEUTICALS AND CYCLIC OLIGOMERS MEYERS, ELIZABETH ANNE 55d

Interview Candidates (20)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17755881 NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS EBBINGHAUS, BRIANA NOEL 217d overdue
17819259 DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES LI, BAO Q 99d overdue
18010456 PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING PETERSON, ERIK T 84d overdue
17663133 LUNG TARGETED ANTICANCER THERAPIES WITH LIPOSOMAL ANNAMYCIN JONES, DAMERON LEVEST 78d overdue
18090471 PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING PETERSON, ERIK T 73d overdue
17553612 USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS BELL, SARA ELIZABETH 66d overdue
18437843 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION HAMMOND, ELLEN CHRISTINA 56d overdue
17764104 IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER PATTERSON, SARAH COOPER 43d overdue

Top Art Units

Art UnitApps
1618 6
1675 6
1671 5
1647 4
1625 4
1643 4
1636 4
1631 4
1615 3
1758 3

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19045950 APPARATUS FOR GENERATING THERAPEUTIC SHOCKWAVES AND APPLICATIONS OF SAME BRUCE, FAROUK A 3797 Other Non-Final OA 8d Pending Feb 05, 2025
18866377 ORTHOPEDIC BALL TIP GUIDEWIRE POSITIONING DEVICE RAMANA, ANURADHA 3775 §103 Non-Final OA 16d overdue Pending Nov 15, 2024
18860498 CONTINUOUS BLOOD FLOW VISUALIZATION WITH LASER SPECKLE CONTRAST IMAGING LI, JOHN DENNY 3798 §103 Non-Final OA 14d Pending Oct 25, 2024
18857661 MAGNETICALLY STEERABLE CATHETER KOLKIN, ADAM D. 3798 §103 Final Rejection 7d Pending Oct 17, 2024
18730176 LABEL-FREE METHODS OF SENSING QIAN, SHIZHI 1795 §112 Non-Final OA 70d Pending Jul 18, 2024
18728323 METHODS AND SYSTEMS FOR DETERMINING LEUKEMIA OR LYMPHOMA LEVELS USING LYMPHOID IMAGES JOHNSON, NICOLE F 3796 §103 Non-Final OA 8d Pending Jul 11, 2024
18754451 METHODS AND COMPOSITIONS FOR ENHANCED DISPERSION OF PHOSPHOR IN A POLYMERIC MATRIX EDMONDSON, LYNNE RENEE 1734 §103 Final Rejection 31d overdue Pending Jun 26, 2024
18750233 ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF MARTINEZ, TARA L 1654 §103 Non-Final OA 16d overdue Pending Jun 21, 2024
18722475 ENDOSCOPIC TUBULAR MINIMALLY INVASIVE SURGICAL SYSTEM LONDON, STEPHEN FLOYD 3795 §103 Non-Final OA 29d overdue Pending Jun 20, 2024
18747735 DETECTING INTER-PERSON CONVERSATIONS USING A SMART WEARABLE DEVICE SCHMIEDER, NICOLE A K 2659 §103 Non-Final OA 59d overdue Pending Jun 19, 2024
18736011 System and Methods to Cover the Continuum of Real-time Decision-Making using a Distributed AI-Driven Search Engine on Visual Internet-of-Things HASAN, SYED HAROON 2154 §103 Final Rejection 110d overdue Pending Jun 06, 2024
18678315 ADDITIVE MANUFACTURING OF POLYMER CERAMICS CHIDIAC, NICHOLAS J 1744 §102 Non-Final OA 50d overdue Pending May 30, 2024
18705061 DRY POWDER COMPOSITIONS COMPRISING EUKARYOTIC CELLS AND METHOD OF THEIR MANUFACTURE AND USE GEMBEH, SHIRLEY V 1615 §103 Non-Final OA 70d Pending Apr 26, 2024
18642504 SYSTEM AND METHODS FOR UNBIASED TRANSFORMER SOURCE CODE VULNERABILITY LEARNING WITH SEMANTIC CODE GRAPH DOAN, TAN 2445 §103 Non-Final OA 98d overdue Pending Apr 22, 2024
18702407 CONCENTRIC TUBE DRILLING ROBOT DEVICE, SYSTEM AND METHOD YANG, ANDREW 3775 §103 Non-Final OA 9d overdue Pending Apr 18, 2024
18701303 Compositions and Methods for Modulating Mitochondrial Function ROBERTS, LEZAH 1612 §103 Non-Final OA 63d Pending Apr 15, 2024
18697325 ENGINEERED VECTORS AND ORGANISMS CONTAINING THE SAME FOR ISOFLAVONE CONVERSION IN THE GUT OGUNBIYI, OLUWATOSIN A 1645 §103 Non-Final OA 9d Pending Mar 29, 2024
18696620 TOOL AND PROCESSES FOR PICK-AND-PLACE ASSEMBLY KOCH, GEORGE R 1745 §103 Non-Final OA 126d overdue Pending Mar 28, 2024
18694076 QUANTITATIVE MAGNETIC RESONANCE IMAGING AND TUMOR FORECASTING NGUYEN, HIEN NGOC 3797 §112 Final Rejection 14d Pending Mar 21, 2024
18605434 NANOSENSORS AND METHODS OF MAKING AND USING NANOSENSORS NGUYEN, HENRY H 1758 Other Non-Final OA 19d Pending Mar 14, 2024
18688180 COMPOSITIONS AND METHODS FOR TREATING BONE INJURIES MEYERS, ELIZABETH ANNE 1617 §103 Non-Final OA 19d overdue Pending Feb 29, 2024
18583340 Compositions and Methods for Targeting Connexin Hemichannels LANDSMAN, ROBERT S 1647 Other Non-Final OA 6d Pending Feb 21, 2024
18437843 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION HAMMOND, ELLEN CHRISTINA 3773 §103 Non-Final OA 56d overdue Pending Feb 09, 2024
18292366 IMPROVED DRUG PROCESSING METHODS TO INCREASE DRUG LOADING SAEED, ALI S 1616 Other Non-Final OA 10d overdue Pending Jan 26, 2024
18414651 SYSTEM AND METHOD FOR EVALUATING AND COACHING SOCIAL COMPETENCIES IN IMMERSIVE VIRTUAL ENVIRONMENTS LANE, DANIEL E 3715 §103 Non-Final OA 23d overdue Pending Jan 17, 2024
18403416 DEVICES AND METHODS FOR IN VIVO TISSUE EVALUATION KIM, SAMUEL CHONG 3791 §103 Non-Final OA 46d overdue Pending Jan 03, 2024
18569842 MORPHABLE BONE FIXATION DEVICE, SYSTEM AND METHOD JOHANAS, JACQUELINE T 3773 §103 Non-Final OA 22d Pending Dec 13, 2023
18566362 DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE WRUBLESKI, MATTHEW JAMES 3781 §103 Non-Final OA 23d Pending Dec 01, 2023
18566008 COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES RAHMANI, NILOOFAR 1691 §103 Non-Final OA 5d Pending Nov 30, 2023
18512313 NON-DESTRUCTIVE DATA ACQUISITION METHOD FOR IOT DEVICES SHAFAYET, MOHAMMED 2116 §103 Non-Final OA 16d Pending Nov 17, 2023
18504509 METHODS, APPARATUSES, AND SYSTEMS FOR ASPIRATING AIRWAYS LE, QUYNH DAO 3781 §103 Non-Final OA 8d overdue Pending Nov 08, 2023
18287013 A Directional Radiofrequency (RF) Ablation Needle PEFFLEY, MICHAEL F 3794 §103 Final Rejection 33d Pending Oct 15, 2023
18287009 Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles SHOMER, ISAAC 1612 §103 Non-Final OA 71d overdue Pending Oct 15, 2023
18286176 A STARTING MODEL INDEPENDENT FULL WAVEFORM INVERSION SYSTEM, METHOD, AND COMPUTER-PROGRAM PRODUCT FOR SUBSURFACE VELOCITY ESTIMATION ISLAM, MOHAMMAD K 2857 §103 Non-Final OA 13d Pending Oct 09, 2023
18286175 PHOTOELECTRODES AND METHODS OF MAKING AND USE THEREOF IMTIAZ, S M SOHEL 2812 §103 Non-Final OA 34d Pending Oct 09, 2023
18472378 SYSTEM FOR GAIT TRAINING ATKINSON, GARRETT K 3784 §102 Non-Final OA 36d overdue Pending Sep 22, 2023
18470177 DYNAMIC ADAPTIVE SCHEDULING FOR ENERGY-EFFICIENT HETEROGENEOUS SYSTEMS-ON-CHIP AND RELATED ASPECTS EWALD, JOHN ROBERT DAKITA 2199 §103 Non-Final OA 11d overdue Pending Sep 19, 2023
18282083 BIARYL AMIDE AND HETEROARYL AMIDES FOR TREATMENT OF CANDIDA ALBICANS INFECTION LEESER, ERICH A 1622 §112 Non-Final OA 62d Pending Sep 14, 2023
18463282 USE OF SDHA AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN UVEAL MELANOMA SALMON, KATHERINE D 1682 §103 Final Rejection 161d overdue Pending Sep 07, 2023
18280427 Loading of Alginate Microspheres BAEK, JONGHWAN NMN 1618 §103 Non-Final OA 75d Pending Sep 05, 2023
18458258 INHALABLE COMPOSITION OF CLOFAZIMINE AND METHODS OF USE THEREOF HAGHIGHATIAN, MINA 1616 §103 Non-Final OA 103d overdue Pending Aug 30, 2023
18457034 METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYS IGBOKO, CHIMA U 3771 §102 Final Rejection 41d Pending Aug 28, 2023
17661411 SWIRL-PINTLE INJECTOR FOR OXY-COAL COMBUSTOR BASICHAS, ALFRED 3762 §103 Non-Final OA 46d overdue Pending Aug 23, 2023
18547687 METHODS FOR POLYPEPTIDE PROCESSING AND ANALYSIS XU, XIAOYUN 1797 §103 Non-Final OA 17d overdue Pending Aug 23, 2023
18547495 METHODS FOR PROGNOSING, DIAGNOSING, AND TREATING COLORECTAL CANCER WOOLWINE, SAMUEL C 1681 §103 Non-Final OA 52d overdue Pending Aug 22, 2023
18449468 POOL-TYPE REACTOR WITH DRAIN TANK GARNER, LILY CRABTREE 3646 §103 Non-Final OA 70d Pending Aug 14, 2023
18546141 LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES MACFARLANE, STACEY NEE 1675 §103 Non-Final OA 26d Pending Aug 11, 2023
18365991 Weight Loss Regimen ANGELL, JON E 1637 Other Non-Final OA 54d Pending Aug 05, 2023
18364714 Explainable Artificial Intelligence Toolset for Extracting Logic Inherent in Machine Learning Models SPIELER, WILLIAM 2159 §102 Non-Final OA 6d Pending Aug 03, 2023
18264125 FLEXIBLE IMPLANTS AND METHODS OF ENHANCED BONE FIXATION HAMMOND, ELLEN CHRISTINA 3773 §103 Final Rejection 16d Pending Aug 03, 2023
18263340 METHODS OF TREATING CANCER WITH POZIOTINIB BELL, SARA ELIZABETH 1625 DPOther Non-Final OA 62d Pending Jul 27, 2023
18359521 EXOSUIT DEVICE AND METHOD FOR EXOSUIT MODELING AND DESIGN MILLER, DANIEL A 3786 §103 Non-Final OA 5d Pending Jul 26, 2023
18262176 Combination Therapy Schedules to Treat Cancer CRAIGO, BAHAR ALAWI 1699 §103 Final Rejection 97d overdue Pending Jul 19, 2023
18261414 CD27-EXTRACELLULAR DOMAIN CAR TO TARGET CD70-POSITIVE TUMORS SHUPE, ELIZABETH A 1643 Other Non-Final OA 35d overdue Pending Jul 13, 2023
18210829 LIVE ATTENUATED ZIKA VIRUS WITH 3'UTR DELETION, VACCINE CONTAINING AND USE THEREOF SALVOZA, M FRANCO G 1672 Other Non-Final OA 6d Pending Jun 16, 2023
18330483 POWERED PROSTHESIS WITH TORQUE DENSE, LOW RATIO ACTUATION PATEL, AREN 3774 §103 Non-Final OA 85d overdue Pending Jun 07, 2023
18330563 SUMO Targeting Morpholinos as both Enhancers of Anti-Cancer Effects of Chemotherapeutic Treatments and Preventative Agents Against the Establishment of Chemoresistance SU-TOBON, QIWEN NMN 1636 §103 Non-Final OA 6d Pending Jun 07, 2023
18200809 Systems, Methods, and Apparatus for Simulation of Complex Subsurface Fracture Geometries Using Unstructured Grids GIRI, PURSOTTAM 2186 §103 Final Rejection 131d overdue Pending May 23, 2023
18253571 METHODS AND COMPOSITIONS COMPRISING MHC CLASS PEPTIDES GURLEY, JAMI MICHELLE 1647 Other Non-Final OA 30d overdue Pending May 18, 2023
18308921 PROACTIVE SEISMIC REHABILITATION OF WATER PIPE NETWORKS FOR EQUITABLE RECOVERY ABOUZAHRA, REHAM K 3625 §101 Non-Final OA 146d overdue Pending Apr 28, 2023
18250645 MUTANT PROTEASES AND USES THEREOF MARTIN, RACHEL E 1657 §112 Non-Final OA 20d Pending Apr 26, 2023
18306038 ICOS TARGETING FOR NEUROPATHIC PAIN RELIEF TRAN HO, LAM THUY VI 1647 §103 Non-Final OA 9d overdue Pending Apr 24, 2023
18249241 COMPOSITIONS AND METHODS FOR MUC18 TARGETING DRISCOLL, MAUREEN VARINA 1644 §112 Non-Final OA 99d overdue Pending Apr 14, 2023
18248339 INDUCTION BY LOW DOSE RADIATION OF CANCER CELL TARGETS FOR CELL-BASED OR SMALL MOLECULE THERAPY REDDY, SUNITA 3791 §103 Non-Final OA 30d overdue Pending Apr 07, 2023
18248193 PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM GRABER, JAMES J 1631 §103 Non-Final OA 5d Pending Apr 06, 2023
18296755 EXOSOME ENCODED IL-10 AS A TREATMENT FOR INFLAMMATION ASSOCIATED ADVERSE PREGNANCY CONDITION ABBAS, SYED JARAR 1674 §103 Non-Final OA 5d overdue Pending Apr 06, 2023
18029293 ATMOSPHERIC WATER HARVESTING SYSTEM KUMAR, PREETI 1761 Other Non-Final OA 31d overdue Pending Mar 29, 2023
18124132 LIGHT EMITTING DIODE (LED) STRUCTURES FOR A MICROLED DEVICE, AND METHOD FOR PRODUCING AN ARRAY OF LED STRUCTURES SMITH, BRADLEY 2817 §103 Non-Final OA 16d overdue Pending Mar 21, 2023
18044877 PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN BASQUILL, SEAN M 1614 §103 Final Rejection 16d overdue Pending Mar 10, 2023
18023483 METHODS FOR FINE NEEDLE SAMPLE ANALYSIS VIA MASS SPECTROMETRY FRITCHMAN, REBECCA M 1758 §101 Final Rejection 71d overdue Pending Feb 27, 2023
18174732 INDIUM BASED SOL-GEL OXIDE PRECURSOR FILMS AS EXTREME ULTRAVIOLET AND LOW-ENERGY ELECTRON BEAM RESISTS TRAYWICK, ANDREW PRESTON 1737 §103 Non-Final OA 184d overdue Pending Feb 27, 2023
18043142 COMBINATION THERAPY OF A RAF INHIBITOR AND A MEK INHIBITOR FOR THE TREATMENT OF SARCOMA PURDY, KYLE A 1611 §103 Final Rejection 31d overdue Pending Feb 27, 2023
18022670 COMPOSITION COMPRISING POLYETHYLENE GLYCOL CONJUGATED TO INDOCYANINE GREEN AND METHODS OF USE CABRAL, ROBERT S 1614 §102 Non-Final OA 45d overdue Pending Feb 22, 2023
18112130 ORGANIC SUBLIMABLE MATERIAL-ASSISTED ELECTRODES YOON, KEVIN E 1735 §103 Non-Final OA 7d Pending Feb 21, 2023
18042362 METHODS OF DEPOSITING FILMS WITH THE SAME STOICHIOMETRIC FEATURES AS THE SOURCE MATERIAL BRATLAND JR, KENNETH A 1714 §103 Final Rejection 8d overdue Pending Feb 21, 2023
18041470 TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY JONES, DAMERON LEVEST 1618 §103 Non-Final OA 21d Pending Feb 13, 2023
18019205 SYSTEMS AND METHODS FOR AUTOMATED, REAL-TIME ANALYSIS AND OPTIMIZATION OF FORMATION-TESTER MEASUREMENTS ALEXANDER, EMMA LYNNE 2857 §103 Non-Final OA 77d overdue Pending Feb 01, 2023
18018546 NANOFABRICATION OF DETERMINISTIC DIAGNOSTIC DEVICES CHIU, MAY LEUNG 1758 §103 Non-Final OA 27d Pending Jan 27, 2023
18018350 SOLIDS ANALYSIS OF DRILLING AND COMPLETION FLUIDS CULLER, JILL E 2853 §103 Final Rejection 72d overdue Pending Jan 27, 2023
18155510 HISTAMINE AND HRH1 SIGNALING ACTIVITY AS BIOMARKERS AND ASSOCIATED METHODS CUNNINGCHEN, KATHLEEN MARY 1646 §103 Non-Final OA 23d overdue Pending Jan 17, 2023
18096167 PSEUDOTYPED VIRUSES CONFIGURED TO EXPRESS CAR IN T-CELLS CHASE, CAROL ANN 1646 §103 Non-Final OA 22d Pending Jan 12, 2023
18094973 NEIL2 PROTEIN THERAPY FOR TREATMENT OF VIRAL INFECTION STEADMAN, DAVID J 1656 Other Final Rejection 46d Pending Jan 09, 2023
18090471 PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING PETERSON, ERIK T 2898 §103 Non-Final OA 73d overdue Pending Dec 28, 2022
18145595 UREA INHIBITORS OF MICRO-RNA JOHNSON, CHRISTOPHER LINDSAY 1691 §103 Final Rejection 53d overdue Pending Dec 22, 2022
18010456 PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING PETERSON, ERIK T 2898 §112 Non-Final OA 84d overdue Pending Dec 15, 2022
18001411 3D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERY BROWE, DAVID 1617 Other Final Rejection 25d overdue Pending Dec 09, 2022
18076315 OMICRON SARS-COV-2 ASSAY BLUMEL, BENJAMIN P 1671 §103 Non-Final OA 63d Pending Dec 06, 2022
18008358 FABRICATION OF OPTICAL ELEMENTS ALANKO, ANITA KAREN 1713 §102 Non-Final OA 6d Pending Dec 05, 2022
18000414 LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL STROMAL CELLS FOR CLINICAL USE EBBINGHAUS, BRIANA NOEL 1632 Other Non-Final OA 4d overdue Pending Dec 01, 2022
17999297 GENETIC PHYSICAL UNCLONABLE FUNCTIONS AND METHODS OF USE THEREOF MCLEOD, AFRICA MHAIRIE 1635 §103 Non-Final OA 7d Pending Nov 18, 2022
17999299 GRANULES FOR 3D PRINTING TECHNOLOGY SZNAIDMAN, MARCOS L 1628 §103 Final Rejection 30d overdue Pending Nov 18, 2022
17980435 BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS CHERNYSHEV, OLGA N 1675 §101 Non-Final OA 28d Pending Nov 03, 2022
17997453 ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER LEE, JAE W 1656 §103 Non-Final OA 9d overdue Pending Oct 28, 2022
17969740 COXIELLA BURNETII AVIRULENT NINE MILE PHASE II VIABLE BACTERIA AND METHODS OF USE MORGAN, BAILEY MICHELLE 1645 §112 Non-Final OA 119d overdue Pending Oct 20, 2022
17996618 LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF LIPPERT, JOHN WILLIAM 1615 §103 Non-Final OA 14d Pending Oct 19, 2022
17960557 GOLF SHAFTS HAVING A VARYING OUTER DIAMETER, INNER DIAMETER, AND/OR WALL THICKNESS AND METHODS FOR MANUFACTURING GOLF SHAFTS USING ADDITIVE MANUFACTURING PAIK, STEVEN SANGYUL 2876 §103 Final Rejection 5d overdue Pending Oct 05, 2022
17914735 REVERSE GENETIC SYSTEM FOR SARS-COV-2 FOLEY, SHANON A 1671 §103 Non-Final OA 42d overdue Pending Sep 26, 2022
17911346 TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME IVANOVA, SVETLANA M 1627 §112 Non-Final OA 28d Pending Sep 13, 2022
17908599 Quantum-Confined Stark Effect Electro-Optic Modulator In Perovskite Quantum Wells Integrated On Silicon CULBERT, CHRISTOPHER A 2815 §103 Non-Final OA 2d overdue Pending Sep 01, 2022
17819268 DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF HOERNER, PAUL ELLSWORTH 1611 Other Final Rejection 4d overdue Pending Aug 11, 2022
17819259 DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES LI, BAO Q 1671 §103 Final Rejection 99d overdue Pending Aug 11, 2022
17929013 METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS QIAN, CELINE X 1637 §103 Non-Final OA 51d overdue Pending Aug 10, 2022
17786917 METHODS FOR TREATING GLIOBLASTOMA GODDARD, LAURA B 1642 §103 Non-Final OA 40d Pending Jun 17, 2022
17757503 T-CELL DEATH ASSOCIATED GENE 8 (TDAG8) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES ZHU, JIANJIAN 1631 Other Non-Final OA 181d overdue Pending Jun 16, 2022
17782976 EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES WITH FIBROSIS CHONG, KIMBERLY 1636 §112 Non-Final OA 66d overdue Pending Jun 06, 2022
17782147 COMBINATION THERAPIES FOR THE TREATMENT OF CANCER JONES, DAMERON LEVEST 1618 §103 Non-Final OA 39d Pending Jun 02, 2022
17748315 ENGINEERED MICROBIAL POPULATION MONTANARI, DAVID A 1632 §103 Non-Final OA 66d overdue Pending May 19, 2022
17747358 MULTIGENIC MVA-SARS-COV-2 VACCINE LI, BAO Q 1671 §112 Non-Final OA 18d overdue Pending May 18, 2022
17756116 LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS SPENCE, JENNIFER SUZANNE 1633 §103 Final Rejection 46d overdue Pending May 17, 2022
17756104 LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF B CELLS LEONARD, ARTHUR S 1631 §103 Final Rejection 19d Pending May 17, 2022
17777102 INCLUSION COMPLEXES OF PHARMACEUTICALS AND CYCLIC OLIGOMERS MEYERS, ELIZABETH ANNE 1617 §103 Final Rejection 55d Pending May 16, 2022
17756078 LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS KONOPKA, CATHERINE ANNE 1635 Other Non-Final OA 20d Pending May 16, 2022
17663133 LUNG TARGETED ANTICANCER THERAPIES WITH LIPOSOMAL ANNAMYCIN JONES, DAMERON LEVEST 1618 §103 Final Rejection 78d overdue Pending May 12, 2022
17755881 NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS EBBINGHAUS, BRIANA NOEL 1632 Other Non-Final OA 217d overdue Pending May 11, 2022
17755887 LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF NK CELLS LEONARD, ARTHUR S 1631 §103 Final Rejection 16d Pending May 11, 2022
17774298 HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOF PATTERSON, SARAH COOPER 1675 §101 Final Rejection 23d overdue Pending May 04, 2022
17773491 INTERNET OF THINGS SECURITY ANALYTICS AND SOLUTIONS WITH DEEP LEARNING POPHAM, JEFFREY D 2432 §103 Final Rejection 29d Pending Apr 29, 2022
17771907 SURFACE-STABILIZED LINIO2 AS HIGH CAPACITY CATHODE FOR LI ION BATTERIES WALLS, CYNTHIA KYUNG SOO 1751 §103 Non-Final OA 59d overdue Pending Apr 26, 2022
17769892 TARGET DELIVERY OF NON-BIOLOGICS THROUGH NANOTECHNOLOGY FOR TISSUE REPAIR DICKINSON, PAUL W 1618 §103 Non-Final OA 14d Pending Apr 18, 2022
17764104 IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER PATTERSON, SARAH COOPER 1675 §103 Final Rejection 43d overdue Pending Mar 25, 2022
17698906 COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS TO TREAT LUNG DISEASE KWON, JOHN SEUNGJAI 1615 §103 Non-Final OA 28d overdue Pending Mar 18, 2022
17761020 METHODS OF TREATING PHOSPHATE CONCENTRATION DISORDERS WITH L-BAIBA DAHLIN, HEATHER RAQUEL 1629 §103 Final Rejection 77d overdue Pending Mar 16, 2022
17635560 IMMUNE CELLS FOR ADOPTIVE CELL THERAPIES DEBERRY, REGINA M 1647 §103 Final Rejection 7d Pending Feb 15, 2022
17584116 COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN AND BREAST CANCER HUTTER, GILLIAN A 1625 §103 Non-Final OA 92d overdue Pending Jan 25, 2022
17568619 BK CHANNEL-MODULATING PEPTIDES AND THEIR USE BALLARD, KIMBERLY 1675 Other Non-Final OA 28d Pending Jan 04, 2022
17553612 USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS BELL, SARA ELIZABETH 1625 Other Final Rejection 66d overdue Pending Dec 30, 2021
17457800 USING MASS SPECTROMETRY TO IDENTIFY ENDOMETRIOSIS TISSUE MUI, CHRISTINE T 1797 §103 Non-Final OA 119d overdue Pending Dec 06, 2021
17615393 A SEMILIQUID SURFACE WITH LIQUID AND SOLID REPELLENCE NELSON, MICHAEL B 1787 §103 Non-Final OA 2d overdue Pending Nov 30, 2021
17611019 METHODS AND COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER WU, JULIE ZHEN QIN 1643 §112 Final Rejection 30d Pending Nov 12, 2021
17604689 COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS MAHLUM, JONATHAN DAVIS 1625 §102 Final Rejection 120d overdue Pending Oct 18, 2021
17604560 COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS ROBINSON, MIKHAIL O'DONNEL 1627 §103 Non-Final OA 12d Pending Oct 18, 2021
17604305 COMPOUNDS AND METHODS FOR IMAGING IMMUNE ACTIVITY MEJIAS, SAMANTHA LEE 1618 §103 Final Rejection 56d overdue Pending Oct 15, 2021
17601405 METHODS AND APPLICATIONS FOR CELL BARCODING RAYMONDA, MATTHEW HAROLD 1684 §103 Final Rejection 20d Pending Oct 04, 2021
17600600 COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE DONOGHUE, BRITTNEY ERIN 1675 §103 Final Rejection 19d overdue Pending Sep 30, 2021
17598780 NUCLEAR-DERIVED EXOSOMES AND METHODS OF USE THEREOF SKOKO III, JOHN JOSEPH 1643 §103 Final Rejection 27d Pending Sep 27, 2021
17471717 RESONANT FILTERS HAVING SIMULTANEOUSLY TUNED CENTRAL WAVELENGTHS AND SIDEBANDS HAYES, MARY A 2874 §103 Final Rejection 14d Pending Sep 10, 2021
17593085 METHODS FOR PRODUCTION OF CAR-NK CELLS AND USE THEREOF SMALL, KATHERINE R 1633 §103 Non-Final OA 16d overdue Pending Sep 08, 2021
17412900 Stable Reporter Flavivirus SIFFORD, JEFFREY MARK 1671 §103 Non-Final OA 30d Pending Aug 26, 2021
17431813 BEE GUT MICROBIAL FORMULATION FOR USE AS A PROBIOTIC FOR IMPROVED BEE HEALTH AND PATHOGEN RESISTANCE EIX, EMILY FAY 1653 §103 Non-Final OA 12d Pending Aug 18, 2021
17310262 METAL CHELATOR COMBINATION THERAPY FOR THE TREATMENT OF CANCER JOHANSEN, PETER N. 1644 §103 Final Rejection 14d Pending Jul 27, 2021
17309426 METHODS FOR EX VIVO EXPANSION OF NATURAL KILLER CELLS AND USE THEREOF LEITH, NANCY J 1636 §103 Final Rejection 42d Pending May 26, 2021
17295747 METHODS OF OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS STONEBRAKER, ALYSSA RAE 1642 §103 Final Rejection 46d overdue Pending May 20, 2021
17235771 BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE NGUYEN, JOHN P 1619 §103 Non-Final OA 17d overdue Pending Apr 20, 2021
17222924 SYSTEM AND METHOD FOR HUMAN ACTION RECOGNITION AND INTENSITY INDEXING FROM VIDEO STREAM USING FUZZY ATTENTION MACHINE LEARNING SMITH, KEVIN LEE 2122 §101 Non-Final OA 66d overdue Pending Apr 05, 2021
17251977 METHOD FOR OPTICAL OPENING OF THE BLOOD-BRAIN BARRIER VOKES, KATHLEEN PAIGE 3783 §103 Non-Final OA 72d Pending Dec 14, 2020
16972259 DETECTION OF IMMUNE CHECKPOINT MOLECULES BY DEGLYCOSYLATION RAMADAN, OMAR 1678 §103 Non-Final OA 19d overdue Pending Dec 04, 2020
17047367 THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES HASAN, KHALEDA B 1636 §103 Non-Final OA 5d overdue Pending Oct 13, 2020
17045467 THERAPEUTIC TARGETING OF ONCOGENES USING EXOSOMES MIDDLETON, DANAYA L 1674 §103 Non-Final OA 13d Pending Oct 05, 2020
17042007 USE OF EXOSOMES FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS ROGERS, ERIC JASON 1638 §112 Final Rejection 9d overdue Pending Sep 25, 2020
16970930 UNIVERSAL ANTIGEN PRESENTING CELLS AND USES THEREOF CHATTIN, AMY MARIE 1643 Other Non-Final OA 23d overdue Pending Aug 18, 2020
16834504 COMPACT FLUID WARMER EKRAMI, YASAMIN 3794 §103 Non-Final OA 19d overdue Pending Mar 30, 2020

Managing BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month